AR118181A2 - IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) - Google Patents
IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC)Info
- Publication number
- AR118181A2 AR118181A2 ARP200100509A ARP200100509A AR118181A2 AR 118181 A2 AR118181 A2 AR 118181A2 AR P200100509 A ARP200100509 A AR P200100509A AR P200100509 A ARP200100509 A AR P200100509A AR 118181 A2 AR118181 A2 AR 118181A2
- Authority
- AR
- Argentina
- Prior art keywords
- amicrocitic
- nsclc
- immunotherapy against
- against various
- various tumors
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a péptidos, ácidos nucleicos y células para la utilización en métodos inmunoterapéuticos. En concreto, la presente se refiere a la inmunoterapia contra el cáncer. La presente se refiere, además, a epítopos peptídicos de linfocitos T citotóxicos (CTL) asociados a tumor, solos o en combinación con otros péptidos asociados a tumor que sirven como principios activos farmacéuticos de composiciones vacunales que estimulan respuestas inmunitarias antitumorales. La presente se refiere a más de 70 nuevas secuencias peptídicas y sus variantes derivadas de moléculas HLA de clase I y clase II de células tumorales humanas que pueden ser utilizadas en composiciones vacunales para desencadenar respuestas inmunitarias antitumorales.The present relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. Specifically, this refers to immunotherapy against cancer. The present further relates to tumor-associated cytotoxic T lymphocyte (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate antitumor immune responses. This refers to more than 70 new peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions to trigger antitumor immune responses.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361862213P | 2013-08-05 | 2013-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR118181A2 true AR118181A2 (en) | 2021-09-22 |
Family
ID=56131705
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140102933A AR097241A1 (en) | 2013-08-05 | 2014-08-05 | IMMUNOTHERAPY AGAINST VARIOUS TUMORS LIKE CANCER OF LUNG, INCLUDING THE CARCINOMA OF PULMON AMICROCÍTICO (NSCLC) |
| ARP200100508A AR118180A2 (en) | 2013-08-05 | 2020-02-26 | IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) |
| ARP200100509A AR118181A2 (en) | 2013-08-05 | 2020-02-26 | IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140102933A AR097241A1 (en) | 2013-08-05 | 2014-08-05 | IMMUNOTHERAPY AGAINST VARIOUS TUMORS LIKE CANCER OF LUNG, INCLUDING THE CARCINOMA OF PULMON AMICROCÍTICO (NSCLC) |
| ARP200100508A AR118180A2 (en) | 2013-08-05 | 2020-02-26 | IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) |
Country Status (1)
| Country | Link |
|---|---|
| AR (3) | AR097241A1 (en) |
-
2014
- 2014-08-05 AR ARP140102933A patent/AR097241A1/en unknown
-
2020
- 2020-02-26 AR ARP200100508A patent/AR118180A2/en unknown
- 2020-02-26 AR ARP200100509A patent/AR118181A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR118180A2 (en) | 2021-09-22 |
| AR097241A1 (en) | 2016-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160717A1 (en) | NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) | |
| CU20160060A7 (en) | PEPTIDES, NUCLEIC ACIDS AND CELLS, USEFUL IN PERSONALIZED IMMUNOTHERAPY AGAINST VARIOUS CEREBRAL AND NEURONAL TUMORS | |
| CR20160531A (en) | NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, LIKE ACUTE MYELOGEN LEUKEMIA (LMA) | |
| PH12021551208A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| CR20170419A (en) | NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCER CANCER AND OTHER TYPES OF CANCER. | |
| AR118180A2 (en) | IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) | |
| AR113131A2 (en) | IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) | |
| MX2019013163A (en) | Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml). | |
| MX2019013161A (en) | Personalized immunotherapy against several neuronal and brain tumors. | |
| AR100926A1 (en) | IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA | |
| MY193910A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| MY194244A (en) | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc | |
| MY194241A (en) | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC | |
| MY194653A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| EA202090822A2 (en) | A NEW METHOD FOR IMMUNOTHERAPY OF SEVERAL TUMORS OF TUMORS SUCH AS LUNG CANCER, INCLUDING NSCLC | |
| EA201990696A1 (en) | PERSONALIZED IMMUNOTHERAPY OF SEVERAL SPECIES OF NEURAL TUMORS AND BRAIN TUMORS |